These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 25736696

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Fluorodeoxyglucose Uptake on Positron Emission Tomography Is a Useful Predictor of Long-Term Pain Control After Palliative Radiation Therapy in Patients With Painful Bone Metastases: Results of a Single-Institute Prospective Study.
    Tahara T, Fujii S, Ogawa T, Michimoto K, Fukunaga T, Tanino T, Uchida N, Matsuki T, Sakamoto H.
    Int J Radiat Oncol Biol Phys; 2016 Feb 01; 94(2):322-8. PubMed ID: 26853340
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
    Calais J, Thureau S, Dubray B, Modzelewski R, Thiberville L, Gardin I, Vera P.
    J Nucl Med; 2015 Feb 01; 56(2):196-203. PubMed ID: 25572091
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differential (18)F-FDG and (18)F-FLT Uptake on Serial PET/CT Imaging Before and During Definitive Chemoradiation for Non-Small Cell Lung Cancer.
    Everitt SJ, Ball DL, Hicks RJ, Callahan J, Plumridge N, Collins M, Herschtal A, Binns D, Kron T, Schneider M, MacManus M.
    J Nucl Med; 2014 Jul 01; 55(7):1069-74. PubMed ID: 24833494
    [Abstract] [Full Text] [Related]

  • 7. Formula corrected maximal standardized uptake value in FDG-PET for partial volume effect and motion artifact is not a prognostic factor in stage I non-small cell lung cancer treated with stereotactic body radiotherapy.
    Yamamoto T, Kadoya N, Shirata Y, Kaneta T, Koto M, Umezawa R, Ishikawa Y, Kubozono M, Sugawara T, Matsushita H, Abe K, Takeda K, Jingu K.
    Ann Nucl Med; 2015 Oct 01; 29(8):666-73. PubMed ID: 26040413
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. FDG PET uptake as a predictor of pain response in palliative radiation therapy in patients with bone metastasis.
    Adli M, Kuzhan A, Alkis H, Andic F, Yilmaz M.
    Radiology; 2013 Dec 01; 269(3):850-6. PubMed ID: 23985277
    [Abstract] [Full Text] [Related]

  • 10. Value of dual time point F-18 FDG-PET/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy.
    Satoh Y, Nambu A, Onishi H, Sawada E, Tominaga L, Kuriyama K, Komiyama T, Marino K, Aoki S, Araya M, Saito R, Maehata Y, Oguri M, Araki T.
    Eur J Radiol; 2012 Nov 01; 81(11):3530-4. PubMed ID: 22178287
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prognostic evaluations of small size lung cancers by 18F-FDG PET/CT and thin-section CT.
    Kishimoto M, Iwano S, Ito S, Kato K, Ito R, Naganawa S.
    Lung Cancer; 2014 Nov 01; 86(2):180-4. PubMed ID: 25263854
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. (18)F-fluorodeoxyglucose positron emission tomography to assess response after radiation therapy in anaplastic thyroid cancer.
    Levy A, Leboulleux S, Lepoutre-Lussey C, Baudin E, Ghuzlan AA, Hartl D, Deutsch E, Deandreis D, Lumbroso J, Tao Y, Schlumberger M, Blanchard P.
    Oral Oncol; 2015 Apr 01; 51(4):370-5. PubMed ID: 25595614
    [Abstract] [Full Text] [Related]

  • 19. Incorporation of the SUVmax Measured From FDG PET and Neutrophil-to-lymphocyte Ratio Improves Prediction of Clinical Outcomes in Patients With Locally Advanced Non-small-cell Lung Cancer.
    Guo D, Jin F, Jing W, Li M, Chen D, Zou B, Jiang G, Fu L, Zhu H, Kong L, Wu J, Yu J, Yue J.
    Clin Lung Cancer; 2019 Nov 01; 20(6):412-419. PubMed ID: 31300364
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.